Lab
Arnett Clinic, LLC
Arnett Clinic, LLC was paid $1.14M by Medicaid between Jan 2018 and Dec 2024, across 96 billing codes. Its largest line is 87651, Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe — 23% of everything it billed.
33Billing provider infoARNETT CLINIC, LLC
LAFAYETTE, IN 47904
LAFAYETTE, IN 47904
33aNPI1881655090assigned 03/29/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.14M
24GClaims156,934
24DCodes billed96
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Indiana
Rank by total paid#13 of 66
Median peer was paid$53K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,008 | $106K | |
| 2019 | 23,898 | $209K | |
| 2020 | 15,256 | $83K | |
| 2021 | 17,924 | $118K | |
| 2022 | 21,516 | $184K | |
| 2023 | 24,043 | $207K | |
| 2024incomplete | 20,289 | $233K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 23% | 11,103 | 9,574 | $259K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18% | 7,850 | 6,658 | $207K |
| 36415 | Collection of venous blood by venipuncture | 11% | 51,693 | 44,225 | $127K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.8% | 7,319 | 6,248 | $89K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.7% | 13,390 | 11,605 | $65K |
| 80050 | General health panel | 3.1% | 1,144 | 1,073 | $36K |
| 80053 | Comprehensive metabolic panel | 2.6% | 5,212 | 4,499 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 3,215 | 2,831 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.1% | 1,440 | 1,254 | $25K |
| 80061 | Lipid panel | 2.1% | 3,218 | 2,992 | $24K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.7% | 3,562 | 3,202 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 2,703 | 2,289 | $15K |
84 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 828 | $12K |
| 80074 | 1.1% | 409 | $12K | |
| 87590 | 1.0% | 928 | $12K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 351 | $11K |
| 87807 | <1% | 1,122 | $10K | |
| 81001 | <1% | 5,478 | $10K | |
| 81025 | <1% | 1,620 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,603 | $9K |
| 82607 | <1% | 957 | $8K | |
| 85027 | <1% | 2,022 | $8K | |
| 84439 | <1% | 1,536 | $7K | |
| 86780 | <1% | 800 | $6K | |
| 87660 | <1% | 439 | $5K | |
| 86703 | <1% | 680 | $5K | |
| 87510 | <1% | 438 | $5K | |
| 87480 | <1% | 438 | $5K | |
| 81002 | <1% | 2,766 | $5K | |
| 84702 | <1% | 597 | $5K | |
| 87210 | <1% | 1,192 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 89 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 404 | $4K |
| 82330 | <1% | 576 | $3K | |
| 85651 | <1% | 1,554 | $3K | |
| 82728 | <1% | 484 | $3K | |
| 82565 | <1% | 1,449 | $3K | |
| 87186 | <1% | 873 | $3K | |
| 87081 | <1% | 838 | $3K | |
| 81003 | <1% | 2,121 | $3K | |
| 86850 | <1% | 743 | $3K | |
| 83550 | <1% | 520 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 221 | $2K |
| 83540 | <1% | 531 | $2K | |
| 87653 | <1% | 190 | $2K | |
| 86762 | <1% | 165 | $2K | |
| 84520 | <1% | 874 | $1K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 157 | $1K |
| 87340 | <1% | 350 | $1K | |
| 85610 | <1% | 636 | $1K | |
| 80047 | <1% | 124 | $1K | |
| 80076 | <1% | 230 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 374 | $1K |
| 82746 | <1% | 101 | $1K | |
| 82950 | <1% | 219 | $956.53 | |
| 84153 | <1% | 73 | $930.78 | |
| 86140 | <1% | 381 | $921.93 | |
| 87522 | Neg quan hep c or qual rna | <1% | 22 | $901.44 |
| 86900 | <1% | 627 | $879.68 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 87 | $868.74 |
| 86901 | <1% | 628 | $864.30 | |
| 80051 | <1% | 458 | $842.98 | |
| 86038 | <1% | 158 | $794.31 | |
| 86039 | <1% | 182 | $777.35 | |
| 86317 | <1% | 66 | $599.19 | |
| 84484 | <1% | 75 | $559.63 | |
| 86706 | <1% | 60 | $538.92 | |
| 82570 | <1% | 225 | $501.63 | |
| 86376 | <1% | 61 | $431.79 | |
| 83735 | <1% | 183 | $415.70 | |
| 86308 | <1% | 96 | $415.61 | |
| 82947 | <1% | 351 | $404.55 | |
| 84295 | <1% | 335 | $348.56 | |
| 82374 | <1% | 329 | $346.19 | |
| 82435 | <1% | 330 | $340.91 | |
| 84132 | <1% | 332 | $334.95 | |
| 83690 | <1% | 89 | $307.17 | |
| 86803 | <1% | 145 | $267.36 | |
| 87276 | <1% | 54 | $257.12 | |
| 82550 | <1% | 54 | $221.70 | |
| 87275 | <1% | 54 | $213.12 | |
| 83516 | <1% | 19 | $196.01 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 14 | $194.00 |
| 87077 | <1% | 61 | $184.07 | |
| 84480 | <1% | 13 | $171.03 | |
| 86704 | <1% | 19 | $163.82 | |
| 87070 | <1% | 42 | $117.09 | |
| 87205 | <1% | 57 | $116.22 | |
| 84156 | <1% | 78 | $109.43 | |
| 82044 | <1% | 25 | $80.99 | |
| 85730 | <1% | 14 | $74.94 | |
| 84550 | <1% | 27 | $61.98 | |
| 81015 | <1% | 48 | $61.00 | |
| 81000 | <1% | 16 | $28.72 | |
| 84460 | 0% | 111 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATMAITAN, ALFONSO (C.E.O.)
Parent organizationARNETT CLINIC, LLC